FDA clears TYBR Health’s gel system for preserving mobility post-surgery
The US Food and Drug Administration (FDA) has granted 510(k) clearance to TYBR Health’s bioresorbable B3 GEL System. The post FDA clears TYBR Health’s gel system for preserving mobility post-surgery appeared first on Medical Device Network.
The US Food and Drug Administration (FDA) has granted 510(k) clearance to TYBR Health’s bioresorbable B3 GEL System.
The post FDA clears TYBR Health’s gel system for preserving mobility post-surgery appeared first on Medical Device Network.
